Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (14)

2022

  1. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500

2021

  1. In Silico Prediction of the Toxic Potential of Neuroprotective Bifunctional Molecules Based on Chiral N-Propargyl-1,2-amino Alcohol Derivatives

    Chemical Research in Toxicology, Vol. 34, Núm. 5, pp. 1245-1249

  2. The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy

    Antioxidants, Vol. 10, Núm. 7

2020

  1. Cerebral ischemia and traumatic brain injury: Protection by melatonin

    Melatonin: Production, Functions and Benefits (Nova Science Publishers, Inc.), pp. 231-255

  2. In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases

    ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801

  3. Melatonin reduces NLRP3 inflammasome activation by increasing α7 nAChR-mediated autophagic flux

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

  4. Melatonin's efficacy in stroke patients; a matter of dose? A systematic review

    Toxicology and Applied Pharmacology, Vol. 392

2019

  1. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics

    Cancers, Vol. 11, Núm. 11

2018

  1. In silico assessment of the metabolism and its safety significance of multitarget propargylamine ASS234

    CNS Neuroscience and Therapeutics

  2. Melatonin: A hypothesis for Kawasaki disease treatment

    Medical Hypotheses, Vol. 119, pp. 6-10

  3. Modulation of Heat Shock Response Proteins by ASS234, Targeted for Neurodegenerative Diseases Therapy

    Chemical Research in Toxicology, Vol. 31, Núm. 9, pp. 839-842

  4. Neuroinflammation Signaling Modulated by ASS234, a Multitarget Small Molecule for Alzheimer's Disease Therapy

    ACS Chemical Neuroscience, Vol. 9, Núm. 12, pp. 2880-2885

2017

  1. Corrigendum: Melatonin and nitrones as potential therapeutic agents for stroke [Front. Aging Neurosci., 8 (2016) (281)] DOI:10.3389/fnagi.2016.00281

    Frontiers in Aging Neuroscience

2016

  1. Melatonin and nitrones as potential therapeutic agents for stroke

    Frontiers in Aging Neuroscience, Vol. 8, Núm. NOV